1 min read
Add as a preferred source on GooglePelthos Therapeutics Shares Fall About 35% After Castle Creek Merger Deal
The reported share price was $10.79. The proposed combination would add cell and gene therapies for serious skin diseases to Pelthos’ portfolio.
Pelthos Therapeutics Inc. (PTHS) shares were at $10.79 Friday, Oct. 30, down about 35% after the company agreed to combine with Castle Creek Biosciences (CCBS).
The proposed deal would broaden Pelthos’ portfolio with cell and gene therapies aimed at serious skin diseases.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.